Friday, September 10, 2010

Holding down health costs: Reuter's story on UK NICE not recommending a new drug

If you are following the healthcare debate you know holding down costs and central to the debate. The UK NHS has a model that works. A panel of experts reviews the cost effectiveness of the treatments.

Here is a story about a tough decision: Whether to extend the benefits of a new, expensive and slighly better schophrenia drug to teenagers.

Reuter's story here


No comments:

Post a Comment